NGS-Based RNA-Sequencing Market by Product & Services (Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services), Technology (Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis), Application, End-User - Global

NGS-Based RNA-Sequencing Market by Product & Services (Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services), Technology (Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis), Application, End-User - Global Forecast 2024-2030


The NGS-Based RNA-Sequencing Market size was estimated at USD 2.32 billion in 2023 and expected to reach USD 2.67 billion in 2024, at a CAGR 17.32% to reach USD 7.12 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the NGS-Based RNA-Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the NGS-Based RNA-Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the NGS-Based RNA-Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Becton, Dickinson and Company, BGI Group, Eurofins Scientific, F. Hoffmann-la Roche AG, Genewiz by Brooks Automation, Inc., Hamilton Company, Illumina, Inc., Merck KGaA, Oxford Nanopore Technologies, PerkinElmer, Inc., Psomagen, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the NGS-Based RNA-Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product & Services

Data Analysis

RNA Sequencing Platforms & Consumables

RNA Sequencing Services

Sample Preparation Products

Storage & Management
Technology

Ion Semiconductor Sequencing

Nanopore Sequencing

Sequencing By Synthesis

Single-Molecule Real-Time Sequencing
Application

De Novo Transcriptome Assembly

Expression Profiling Analysis

Small RNA Sequencing

Variant Calling & Transcriptome Epigenetics
End-User

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Research & Academia
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the NGS-Based RNA-Sequencing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the NGS-Based RNA-Sequencing Market?
3. What are the technology trends and regulatory frameworks in the NGS-Based RNA-Sequencing Market?
4. What is the market share of the leading vendors in the NGS-Based RNA-Sequencing Market?
5. Which modes and strategic moves are suitable for entering the NGS-Based RNA-Sequencing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. NGS-Based RNA-Sequencing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the adoption of next-generation sequencing
5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
5.1.2. Restraints
5.1.2.1. Cost of NGS instruments is high
5.1.3. Opportunities
5.1.3.1. Technological advancement in the RNA-Sequencing
5.1.3.2. Increasing research activities related to RNA-Sequencing
5.1.4. Challenges
5.1.4.1. Unavailability of skilled manpower
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. NGS-Based RNA-Sequencing Market, by Product & Services
6.1. Introduction
6.2. Data Analysis
6.3. RNA Sequencing Platforms & Consumables
6.4. RNA Sequencing Services
6.5. Sample Preparation Products
6.6. Storage & Management
7. NGS-Based RNA-Sequencing Market, by Technology
7.1. Introduction
7.2. Ion Semiconductor Sequencing
7.3. Nanopore Sequencing
7.4. Sequencing By Synthesis
7.5. Single-Molecule Real-Time Sequencing
8. NGS-Based RNA-Sequencing Market, by Application
8.1. Introduction
8.2. De Novo Transcriptome Assembly
8.3. Expression Profiling Analysis
8.4. Small RNA Sequencing
8.5. Variant Calling & Transcriptome Epigenetics
9. NGS-Based RNA-Sequencing Market, by End-User
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Pharmaceutical & Biotechnology Companies
9.4. Research & Academia
10. Americas NGS-Based RNA-Sequencing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific NGS-Based RNA-Sequencing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies
14.1.2. Becton, Dickinson and Company
14.1.3. BGI Group
14.1.4. Eurofins Scientific
14.1.5. F. Hoffmann-la Roche AG
14.1.6. Genewiz by Brooks Automation, Inc.
14.1.7. Hamilton Company
14.1.8. Illumina, Inc.
14.1.9. Merck KGaA
14.1.10. Oxford Nanopore Technologies
14.1.11. PerkinElmer, Inc.
14.1.12. Psomagen
14.1.13. Qiagen N.V.
14.1.14. Takara Bio Inc.
14.1.15. Thermo Fisher Scientific
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2023 VS 2030
FIGURE 3. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
FIGURE 7. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
FIGURE 8. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings